Management of Invasive Infections due to a Rare Arthroconidial Yeast, Saprochaete capitata, in Two Patients with Acute Hematological Malignancies.
Francesca GurrieriSilvia CorbelliniGiorgio PiccinelliAlessandro TurraEnrico MorelloMichele MalagolaDomenico RussoArnaldo CarusoMaria Antonia De FrancescoPublished in: Vaccines (2021)
Saprochaete capitata is an arthroconidial yeast, found principally in the environment, even if it belongs also to the normal microbial flora that colonize human subjects. This yeast is increasingly associated with invasive infections in hematological patients, in particular in those affected by acute leukemia. An important risk factor that predisposes to this infection is the profound neutropenia present in such immunocompromised patients. Saprochaete spp. were found resistant to both echinocandins and fluconazole so the treatment is often difficult. Here, we report two cases of sepsis in two patients with acute leukemia. All of them had fatal events, due to the worsening of their clinical condition. An early diagnosis and appropriate management of these pathogens is important in consideration of the poor prognosis associated to these fungal invasive infections.
Keyphrases
- poor prognosis
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- long non coding rna
- intensive care unit
- endothelial cells
- risk factors
- patient reported outcomes
- microbial community
- saccharomyces cerevisiae
- cell wall
- patient reported
- mechanical ventilation
- chemotherapy induced
- genetic diversity